Clearside Financial Statements From 2010 to 2024
CLM Stock | EUR 0.97 0.05 4.90% |
Check Clearside Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearside Biomedical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Clearside financial statements analysis is a perfect complement when working with Clearside Biomedical Valuation or Volatility modules.
Clearside |
Clearside Biomedical Company Revenue Analysis
Clearside Biomedical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Clearside Biomedical Revenue | 29.57 M |
Most of Clearside Biomedical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clearside Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Based on the latest financial disclosure, Clearside Biomedical reported 29.57 M of revenue. This is much higher than that of the sector and significantly higher than that of the Revenue industry. The revenue for all Germany stocks is notably lower than that of the firm.
Clearside Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clearside Biomedical's current stock value. Our valuation model uses many indicators to compare Clearside Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clearside Biomedical competition to find correlations between indicators driving Clearside Biomedical's intrinsic value. More Info.Clearside Biomedical is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Clearside Biomedical is about 4,556,499 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clearside Biomedical's earnings, one of the primary drivers of an investment's value.About Clearside Biomedical Financial Statements
Clearside Biomedical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Clearside Biomedical investors may analyze each financial statement separately, they are all interrelated. The changes in Clearside Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearside Biomedical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearside Stock Analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.